Global Acid Citrate Dextrose (ACD) Tubes Market Size By Type (6.0 mL, 8.5 mL), By Application (Hospitals, Diagnostics Centers), By Region, And Segment Forecasts, 2023 to 2032

The Global Acid Citrate Dextrose (ACD) Tubes Market was valued at USD 472 million in 2023 and is projected to reach USD 798 million by 2031, expanding at a CAGR of 6.7% during the forecast period of 2023-2031. The growth of the ACD tubes market is driven by the increasing demand for advanced blood collection systems, rising prevalence of blood-related disorders, and growing applications of ACD tubes in clinical laboratories, blood banks, and research institutions. ACD tubes are primarily used for blood specimen collection and preservation, offering superior anticoagulation properties essential for specialized testing and procedures like HLA typing, flow cytometry, and DNA extraction.

Drivers:

Rising Demand for Safe and Reliable Blood Collection:

Increasing focus on patient safety, reduced risk of sample contamination, and accurate laboratory results are boosting the adoption of ACD tubes across healthcare settings.

Growing Prevalence of Blood Disorders:

The rising incidence of hematological disorders and autoimmune diseases is driving the need for efficient blood collection and storage solutions, propelling the market growth.

Expansion of Clinical Laboratories and Blood Banks:

Growing investments in healthcare infrastructure, especially in emerging markets, and the increasing number of diagnostic laboratories and blood banks support the demand for ACD tubes.

Restraints:

High Cost of Specialty Tubes:

Compared to conventional blood collection tubes, ACD tubes are more expensive due to their specific composition and targeted applications, which may limit adoption in cost-sensitive markets.

Availability of Alternatives:

The availability of other anticoagulant tubes like EDTA and Heparin tubes for routine blood tests may act as a restraint to the ACD tubes market growth.

Opportunity:

Technological Advancements in Blood Collection Devices:

Innovations in tube materials, safety features, and compatibility with automated systems provide lucrative opportunities for market players to develop advanced ACD tube products.

Emerging Markets Expansion:

Increasing healthcare expenditure, growing awareness regarding safe blood handling, and rising medical tourism in Asia-Pacific and Latin America present significant growth opportunities.

Market by System Type Insights:

Based on system type, the ACD-A Tubes segment held the largest share in 2023. These tubes are widely used for specialized procedures requiring the preservation of cellular integrity, such as flow cytometry and HLA typing. The ACD-B Tubes segment is expected to witness notable growth due to its increasing use in genetic research and stem cell therapy.

Market by End-use Insights:

Hospitals dominated the market in 2023, contributing over 40% of the revenue share. Hospitals require large volumes of blood collection tubes for various diagnostic procedures. The Blood Banks segment is projected to register the highest growth during the forecast period owing to the rising need for safe and efficient blood storage solutions.

Market by Regional Insights:

North America led the global ACD tubes market in 2023, attributed to advanced healthcare infrastructure, increased adoption of specialized diagnostic procedures, and the presence of key manufacturers. Asia-Pacific is anticipated to witness the highest growth rate during the forecast period, driven by expanding healthcare facilities, growing awareness, and increasing government initiatives for blood safety in countries like China and India.

Competitive Scenario:

Key players operating in the Global Acid Citrate Dextrose (ACD) Tubes Market include BD (Becton, Dickinson and Company), Greiner Bio-One International GmbH, Terumo Corporation, Cardinal Health, Sarstedt AG & Co. KG, FL Medical, Medtronic, Kabe Labortechnik GmbH, and Zhejiang Gongdong Medical Technology Co., Ltd. These companies are focusing on product innovation, strategic collaborations, and regional expansion to strengthen their market position.

Key Market Developments:

In 2023, BD launched an enhanced line of ACD tubes compatible with automated blood processing systems to improve efficiency and accuracy in laboratory operations.

In 2024, Greiner Bio-One expanded its product portfolio with eco-friendly ACD tubes designed to minimize environmental impact while ensuring optimal specimen quality.

In 2025, Terumo Corporation partnered with leading healthcare providers to supply ACD tubes for advanced genetic and stem cell research applications in Asia-Pacific.

Scope of Work – Global Acid Citrate Dextrose (ACD) Tubes Market

Report Metric Details

Market Size (2023) USD 472 Million

Projected Market Size (2031) USD 798 Million

CAGR (2023-2031) 6.7%

Key Segments by System Type ACD-A Tubes, ACD-B Tubes

Key Segments by End-Use Hospitals, Blood Banks, Diagnostic Laboratories

Leading Region North America

Key Players BD, Greiner Bio-One, Terumo Corporation, Cardinal Health, Sarstedt, FL Medical, Medtronic, Kabe Labortechnik, Zhejiang Gongdong Medical Technology

Growth Drivers Rising demand for safe blood collection, growing prevalence of blood disorders, expansion of clinical labs and blood banks

Opportunities Technological advancements, expansion in emerging markets

FAQs – Global Acid Citrate Dextrose (ACD) Tubes Market:

1. What is the current market size of the Global Acid Citrate Dextrose (ACD) Tubes Market?

The Global Acid Citrate Dextrose (ACD) Tubes Market was valued at USD 472 million in 2023.

2. What is the major growth driver of the Global Acid Citrate Dextrose (ACD) Tubes Market?

The major growth driver is the rising demand for safe and reliable blood collection and storage solutions across healthcare settings.

3. Which is the largest region during the forecast period in the Global Acid Citrate Dextrose (ACD) Tubes Market?

North America holds the largest share in the market due to its advanced healthcare infrastructure and higher adoption of specialized diagnostic procedures.

4. Which segment accounted for the largest market share in the Global Acid Citrate Dextrose (ACD) Tubes Market?

The ACD-A Tubes segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Acid Citrate Dextrose (ACD) Tubes Market?

Key players include BD, Greiner Bio-One, Terumo Corporation, Cardinal Health, Sarstedt, FL Medical, Medtronic, Kabe Labortechnik, and Zhejiang Gongdong Medical Technology.

Let me know if you'd like me to prepare a presentation or visual summary based on this report!